Use of Everolimus in Liver Transplantation: Recommendations From a Working Group. - Wikidata - wikimedia - TriplyDB

Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.

Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.

http://www.wikidata.org/entity/Q37605371

about

Use of everolimus in liver transplantation.

P2860

Q41505537-CDBCBE66-21B1-4410-B06B-ECC199FF81A0

P2860

Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.

http://www.wikidata.org/entity/Q37605371

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 August 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.

@en

Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.

@nl

type

label

Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.

@en

Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.

@nl

prefLabel

Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.

@en

Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.

@nl

P1433

Q37605371-FF54CFBA-2DA8-497B-A15A-361F03A098B0

P1476

Q37605371-0A464702-4DE5-42EC-9344-1E4FB0923CFA

P2093

Q37605371-0AC77ABC-5BEB-4BD3-9A66-E704647DA62D

Q37605371-2CE1968E-F263-4764-B1AE-E9BB3542C80A

Q37605371-7FAE1B30-AE57-463E-977D-23A888A890E4

Q37605371-83500862-4EAF-4CB5-A304-EB29C4280179

Q37605371-D952DFE5-F309-40ED-A571-A06BDD858FD5

Q37605371-E51EA3BE-B4C7-4B25-92A7-20B1C129A6E1

P275

Q37605371-C6394A93-DDC3-41B9-BD1E-E65487724875

P2860

Q37605371-018EC1B1-DDB3-4AE6-84C0-20AE143CB241

Q37605371-02639C3F-442A-48E9-BAE6-6ED77F77FC92

Q37605371-137BBEC9-6BC9-4626-8CB5-98CD81F87BD6

Q37605371-13B43D96-61ED-48FC-B303-0D047B476263

Q37605371-1F9AED81-0CDA-42F5-A410-3C666FFB0B3C

Q37605371-206746C5-3326-47F6-8AD7-5DBAF5286AA7

Q37605371-20C8D0E9-14CC-4F1A-B643-C108F9916FBB

Q37605371-243F4048-DAE9-4416-8CBE-B8EABC15EB51

Q37605371-30E29213-69E1-4498-AB4D-4962727567CC

Q37605371-326A4E42-0B92-4347-87E9-1705655679F4

P304

Q37605371-327BDC83-2EAA-464F-8CAD-1F6FE2B846D3

P31

Q37605371-2BC9AEF0-15C2-49B2-9CDA-FEC68BDD2287

P356

Q37605371-36A90EFC-866A-4EAB-BF82-0B1CF8A92A71

P433

Q37605371-AFA4E308-C3C8-4911-A179-1DB655C5A776

P478

Q37605371-E85535AF-AC36-4E54-B898-B58674CFCE4C

P50

Q37605371-AE297075-E785-4ED7-9143-A7FA71D4998E

Q37605371-E263397B-01B8-40BE-BAE7-F923EA5626D8

P577

Q37605371-C847DA71-D874-40D7-AAC2-0FA71AA40960

P698

Q37605371-7FC20692-4A34-4EAB-A2D5-B12DB0CA35B0

P921

Q37605371-17922D99-5744-4E5E-804A-F3D1669A95A1

Q37605371-371C1A34-6F71-4D8F-B2B8-6A8E7A2C6752

Q37605371-547EC187-5FB3-435A-BBC0-46B7BD43AF46

Q37605371-DC5ECE1E-C0C1-4F73-B89F-67DFA741304B

P932

Q37605371-30EC23CF-514F-443C-AA75-C7220485BEC0

P356

TP.0000000000001438

P1433

Transplantation

P1476

Use of Everolimus in Liver Transplantation: Recommendations From a Working Group

@en

P2093

Consensus Panel

http://www.w3.org/2001/XMLSchema#string

Giuseppe Tisone

http://www.w3.org/2001/XMLSchema#string

Luciano De Carlis

http://www.w3.org/2001/XMLSchema#string

Matteo Cescon

http://www.w3.org/2001/XMLSchema#string

Paolo De Simone

http://www.w3.org/2001/XMLSchema#string

Stefano Fagiuoli

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Do wound complications or lymphoceles occur more often in solid organ transplant recipients on mTOR inhibitors? A systematic review of randomized controlled trials

Chronic renal failure after transplantation of a nonrenal organ

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Clinical pharmacokinetics of everolimus.

Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results.

American College of Chest Physicians consensus statement on the management of dyspnea in patients with advanced lung or heart disease.

Wound healing complications and the use of mammalian target of rapamycin inhibitors in kidney transplantation: a critical review of the literature.

Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation.

Immunosuppressive drugs for kidney transplantation.

Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.

P304

239-251

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TP.0000000000001438

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

Riccardo Volpes

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27495768

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation

mechanism of action

P932

5265697

http://www.w3.org/2001/XMLSchema#string